TRIL

Trillium Therapeutics Inc.
TRIL

Overview Fund Activity
Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

32 hedge funds and large institutions have $51.3M invested in Trillium Therapeutics Inc. in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$6.12M
2
PCA
2
Private Capital Advisors
Connecticut
$2.17M
3
ACA
3
Avoro Capital Advisors
New York
$4.67M
4
EAM
4
EverPoint Asset Management
Connecticut
$4.43M
5
PC
5
Polar Capital
United Kingdom
$488K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$254K
2
OAM
2
Oxford Asset Management
United Kingdom
$247K
3
OM
3
Opaleye Management
Massachusetts
$2.59M
4
KPF
4
K2 Principal Fund
Ontario, Canada
$0
5
TC
5
TFS Capital
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
26
Prelude Capital Management
New York
$6K +$3K +200 +100%
Bank of America
27
Bank of America
North Carolina
$6K +$5.97K +398 +19,900%
Morgan Stanley
28
Morgan Stanley
New York
$6K +$6K +400 New
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$4K +$2.37K +154 +145%
UBS Group
30
UBS Group
Switzerland
$3K +$510 +34 +20%
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$1K -$3.08K -151 -76%
Toronto Dominion Bank
32
Toronto Dominion Bank
Ontario, Canada
$1K +$206 +13 +26%
KPF
33
K2 Principal Fund
Ontario, Canada
– -$131K -14,614 Closed
TC
34
TFS Capital
Pennsylvania
– -$107K -11,903 Closed
1
2